SGLT2 inhibition attenuates arterial dysfunction and decreases vascular F-actin content and expression of proteins associated with oxidative stress in aged mice
2022 · GeroScience · 54 citations
https://doi.org/10.1007/s11357-022-00563-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
145
Citations
6
h-index
5
i10-index
Francisco J. Cabral-Amador is an academic researcher from The University of Texas Rio Grande Valley. The author has contributed to research in topics: Diabetes Treatment and Management & Cardiovascular Health and Disease Prevention & Adipose Tissue and Metabolism. The author has an h-index of 6, co-authored 9 publications.
ORCID: 0000-0001-5985-0323Click to start Chat